Publication | Open Access

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast cancer

Bone LossBreast OncologyGeneticsHuman PolymorphismPathologyAromataseBreast CancerCancer GeneticsMedicineCyp19a1 GeneCancer ResearchEndocrine-related Cancer